SciBase Letter from the CEO no 3: Future trends and technologies
Following two recent industry events in March, one in the US and one on our main market Germany, it is always interesting to reflect on our industry, its trends and the areas that might be the focus in the future. Of special interest is the annual meeting of the American Academy of Dermatology (AAD). Held in March, it is the largest and most influential meeting of the year in the US. The AAD has more than 19,000 members, which means that almost all US Dermatologists are members. Because Nevisense is not yet approved in the US, there are limitations on how actively we can market Nevisense